4671.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan...

Stats
Šios dienos apimtis	12 100.00
Vidutinė apimtis	25 977.00
Rinkos kapitalizacija	23.18B
EPS	¥0 ( 2024-02-08 )
Kita pelno data	( ¥0 ) 2024-05-09
Last Dividend	¥36.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	12.01
ATR14	¥2.68 (0.12%)

FALCO HOLDINGS Co., Ltd. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

FALCO HOLDINGS Co., Ltd. Finansinės ataskaitos

Annual	2022
Pajamos:	¥46.91B
Bruto pelnas:	¥14.64B (31.22 %)
EPS:	¥215.22

FY	2022
Pajamos:	¥46.91B
Bruto pelnas:	¥14.64B (31.22 %)
EPS:	¥215.22

FY	2022
Pajamos:	¥50.01B
Bruto pelnas:	¥17.32B (34.64 %)
EPS:	¥339.00

FY	2021
Pajamos:	¥43.61B
Bruto pelnas:	¥13.70B (31.41 %)
EPS:	¥178.61

Financial Reports:

No articles found.

FALCO HOLDINGS Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥32.00 (N/A)	¥0 (N/A)	¥36.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

FALCO HOLDINGS Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.35 - Decrease likely (33.07%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.00	2005-03-15
Last Dividend	¥36.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	31	--
Total Paid Out	¥472.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.35	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.35
Div. Directional Score	6.81	--

Next Divdend (Est)
(2024-05-13)

¥0 Estimate 0.00 %

Dividend Stability

0.08 Very Bad

Dividend Score

3.35

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6203.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4929.T	Ex Dividend Junior	2024-03-18	Annually	0.00%
4099.T	Ex Dividend Junior	2023-12-28	Semi-Annually	0.00%
3315.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2384.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
9312.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8043.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
7287.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6538.T	Ex Dividend Junior	2024-03-28	Sporadic	0.00%
5821.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0460	1.500	9.08	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0541	1.200	8.20	9.83	[0 - 0.3]
returnOnEquityTTM	0.0765	1.500	-0.261	-0.391	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.30	0.800	3.49	2.79	[1 - 3]
quickRatioTTM	1.892	0.800	3.58	2.86	[0.8 - 2.5]
cashRatioTTM	1.171	1.500	4.61	6.91	[0.2 - 2]
debtRatioTTM	0.0136	-1.500	9.77	-10.00	[0 - 0.6]
interestCoverageTTM	182.64	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	184.51	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	184.51	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0194	-1.500	9.92	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.301	1.000	8.32	8.32	[0.2 - 0.8]
operatingProfitMarginTTM	0.0463	1.000	-1.073	-1.073	[0.1 - 0.6]
cashFlowToDebtRatioTTM	4.02	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.176	0.800	5.49	4.40	[0.5 - 2]
Total Score				10.26

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.93	1.000	8.90	0	[1 - 100]
returnOnEquityTTM	0.0765	2.50	-0.168	-0.391	[0.1 - 1.5]
freeCashFlowPerShareTTM	184.51	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.43	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	184.51	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.133	1.500	-2.45	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0464	1.000	-1.341	0	[0.1 - 0.5]
Total Score				3.35

FALCO HOLDINGS Co., Ltd.

FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.